420 related articles for article (PubMed ID: 25433931)
1. [T-cell prolymphocytic leukemia: potential diagnostic pitfalls].
Dessart P; Lemaire P; Le Dû K; Sandrini J; Prophette B; Maillard H
Ann Dermatol Venereol; 2014 Dec; 141(12):777-81. PubMed ID: 25433931
[TBL] [Abstract][Full Text] [Related]
2. A new case of Sézary cell leukemia: a morphological variant of prolymphocytic leukemia.
Pérez-Vila Mf; Espinet B; Solé F; Pedro C; Woessner S; Florensa L
Haematologica; 2000 Jul; 85(7):775-6. PubMed ID: 10897140
[No Abstract] [Full Text] [Related]
3. Generalized leukaemia cutis from a small cell variant of T-cell prolymphocytic leukaemia presenting with exfoliative dermatitis.
Jeong KH; Lew BL; Sim WY
Acta Derm Venereol; 2009; 89(5):509-12. PubMed ID: 19734979
[TBL] [Abstract][Full Text] [Related]
4. Papuloerythroderma-like cutaneous involvement of a CD62L
Nakagawa Y; Hamada T; Matsuda M; Kanno T; Kondo T; Takahashi T; Watanabe T; Okada K; Kawakami T; Miyake T; Morizane S; Iwatsuki K
J Dermatol; 2019 Jan; 46(1):65-69. PubMed ID: 30450688
[TBL] [Abstract][Full Text] [Related]
5. [Peripheral T-cell lymphoma and leukemia (description of 4 cases and review of the literature)].
Rupniewska ZM; Wach M; Antosz H; Zmysłowska A; Roliński J
Pol Arch Med Wewn; 1992 Mar; 87(3):209-24. PubMed ID: 1523149
[No Abstract] [Full Text] [Related]
6. [Successful treatment of T-cell prolymphocytic leukemia (T-PLL) with fludarabine monophosphate].
Maeda A; Iwai K; Ishibashi T
Rinsho Ketsueki; 2009 Aug; 50(8):658-62. PubMed ID: 19915381
[TBL] [Abstract][Full Text] [Related]
7. Utility of flow cytometry immunophenotyping and DNA ploidy studies for diagnosis and characterization of blood involvement in CD4+ Sézary's syndrome.
Lima M; Almeida J; dos Anjos Teixeira M; Queiros ML; Santos AH; Fonseca S; Balanzategui A; Justica B; Orfao A
Haematologica; 2003 Aug; 88(8):874-87. PubMed ID: 12935975
[TBL] [Abstract][Full Text] [Related]
8. The diagnosis of Sézary syndrome on peripheral blood by flow cytometry requires the use of multiple markers.
Klemke CD; Brade J; Weckesser S; Sachse MM; Booken N; Neumaier M; Goerdt S; Nebe TC
Br J Dermatol; 2008 Sep; 159(4):871-80. PubMed ID: 18652582
[TBL] [Abstract][Full Text] [Related]
9. [Cerebriform variant type of T cell prolymphocytic leukemia: Report of one case].
Peña C; Valladares X; Soto C; Encina A; Marinov N; Undurraga MS; Cabrera ME
Rev Med Chil; 2016 Jan; 144(1):124-8. PubMed ID: 26998991
[TBL] [Abstract][Full Text] [Related]
10. T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism.
Magro CM; Morrison CD; Heerema N; Porcu P; Sroa N; Deng AC
J Am Acad Dermatol; 2006 Sep; 55(3):467-77. PubMed ID: 16908353
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of chemotherapy-refractory Sézary syndrome with alemtuzumab (Campath-1H).
Gautschi O; Blumenthal N; Streit M; Solenthaler M; Hunziker T; Zenhäusern R
Eur J Haematol; 2004 Jan; 72(1):61-3. PubMed ID: 14962265
[TBL] [Abstract][Full Text] [Related]
12. Infiltration of the thyroid gland by T-cell prolymphocytic leukemia.
Fujiwara K; Fukuhara T; Kitano H; Okazaki T
Thyroid; 2014 Aug; 24(8):1314-8. PubMed ID: 24762052
[TBL] [Abstract][Full Text] [Related]
13. Leonine facies: A unique presentation of T-prolymphocytic leukemia.
Hasan F; Parashar Y; Rao RN; Kashyap R
Indian J Pathol Microbiol; 2021; 64(4):817-819. PubMed ID: 34673613
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous presentation of T-cell prolymphocytic leukemia.
Ventre MO; Bacelieri RE; Lazarchick J; Pollack RB; Metcalf JS
Cutis; 2013 Feb; 91(2):87-91. PubMed ID: 23513557
[TBL] [Abstract][Full Text] [Related]
15. Mature T-cell leukemias including T-prolymphocytic leukemia, adult T-cell leukemia/lymphoma, and Sézary syndrome.
Foucar K
Am J Clin Pathol; 2007 Apr; 127(4):496-510. PubMed ID: 17369126
[TBL] [Abstract][Full Text] [Related]
16. T-cell prolymphocytic leukemia (T-PLL) with overlapping cytomorphological features with T-CLL and T-ALL: a case initially diagnosed by fine-needle aspiration cytology and immunocytochemistry.
Das DK; Pathan SK; Joneja M; Al-Musawi FA; John B; Mirza KR
Diagn Cytopathol; 2013 Apr; 41(4):360-5. PubMed ID: 21987484
[TBL] [Abstract][Full Text] [Related]
17. T-cell receptor gammadelta T-cell leukemia with the morphology of T-cell prolymphocytic leukemia and a postthymic immunophenotype.
Sugimoto T; Imoto S; Matsuo Y; Kojima K; Yasukawa M; Murayama T; Kohfuku J; Mizuno I; Yakushijin K; Sada A; Nishimura R; Koizumi T
Ann Hematol; 2001 Dec; 80(12):749-51. PubMed ID: 11797117
[TBL] [Abstract][Full Text] [Related]
18. CD30-positive EBV-associated diffuse large B-cell lymphoma occurring after immunosuppressive therapy for T-cell prolymphocytic leukemia.
Alduaij A; Treaba DO; Winer ES
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):64-7. PubMed ID: 21454193
[TBL] [Abstract][Full Text] [Related]
19. Recurrence of T-Cell Prolymphocytic Leukemia With a Rare Presentation as Diffuse Generalized Skin Lesion.
Wasifuddin M; Sabzposh H; Sun L; Wu R; Wang JC
J Investig Med High Impact Case Rep; 2023; 11():23247096231176223. PubMed ID: 37219076
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotypic characterization of T-cell prolymphocytic leukemia.
Chen X; Cherian S
Am J Clin Pathol; 2013 Nov; 140(5):727-35. PubMed ID: 24124154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
